Question 1

Does ExodusPoint Capital Management own VKTX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, ExodusPoint Capital Management holds 361,126 shares of VKTX (Viking Therapeutics), worth $14.1M.

Question 2

How many shares of VKTX does ExodusPoint Capital Management own?

Accepted Answer

As of its Q2 2026 13F, ExodusPoint Capital Management holds 361,126 shares of VKTX (Viking Therapeutics).

Question 3

What is ExodusPoint Capital Management's VKTX position worth?

Accepted Answer

As of its Q2 2026 13F, ExodusPoint Capital Management's VKTX position is worth $14.1M.

Question 4

Is ExodusPoint Capital Management buying or selling VKTX?

Accepted Answer

In Q2 2026, ExodusPoint Capital Management increased its VKTX position from 69,627 to 361,126 shares.

Question 5

When did ExodusPoint Capital Management first buy VKTX?

Accepted Answer

ExodusPoint Capital Management first reported VKTX in its Q2 2019 13F and has listed it in 20 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	361,126	+418.7%	$14.1M	0.1%	$39.01	45
2026-Q1	Decreased	69,627	-90.4%	$2.3M	0.0%	$32.54	0
2025-Q4	Increased	722,199	+253.7%	$25.4M	0.2%	$35.18	55
2025-Q3	Increased	204,190	+427.4%	$5.4M	0.1%	$26.28	44
2025-Q2	Decreased	38,716	-88.9%	$1M	0.0%	$26.50	0
2025-Q1	Increased	349,810	+48.5%	$8.4M	0.1%	$24.15	38
2024-Q4	Decreased	235,503	-10.5%	$9.5M	0.1%	$40.24	0
2024-Q3	Increased	263,159	+397.2%	$16.7M	0.1%	$63.31	54